TTNP
Titan Pharmaceuticals
TTNP
TTNP
Delisted
TTNP was delisted on the 1st of October, 2025.
47 hedge funds and large institutions have $14.1M invested in Titan Pharmaceuticals in 2016 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 11 increasing their positions, 4 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 8
17% less capital invested
Capital invested by funds: $17M → $14.1M (-$2.9M)
Holders
47
Holding in Top 10
–
Calls
$1.11M
Puts
$6K
Top Buyers
| 1 | +$620K | |
| 2 | +$586K | |
| 3 | +$345K | |
| 4 |
SO
STRS Ohio
Columbus,
Ohio
|
+$315K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$260K |
Top Sellers
| 1 | -$305K | |
| 2 | -$146K | |
| 3 | -$141K | |
| 4 |
SG Americas Securities
New York
|
-$96K |
| 5 |
Walleye Trading
New York
|
-$89K |